Armine Matevossian

Armine Matevossian is a Principal Scientist at EMD Serono, Inc., where tenure began in May 2019, following previous roles as Senior Scientist. Prior experience includes serving as a Post-Doctoral Scholar at Novartis Institutes for BioMedical Research from July 2015 to April 2019, and a Doctoral Candidate at Memorial Sloan-Kettering Cancer Center from June 2009 to May 2015, with research focused on Hedgehog acyltransferase in breast cancer and Paf's function in the hematopoietic system. Additional experience includes research technician roles at the Center of Cancer Systems Biology and undergraduate research at the University of Massachusetts Amherst. Armine Matevossian earned a Ph.D. in Cancer Biology from Gerstner Sloan Kettering Graduate School and holds a Bachelor's degree in Biochemistry and Molecular Biology from the University of Massachusetts Amherst.